BHARATBIOTECH

Covaxin Phase 2-3 clinical tests for children are completed by Bharat Biotech

The Phase 2 and 3 clinical trials for Coronavirus vaccine (covaxin) for age 2 to 18 years have been completed…

3 years ago

Mandaviya: The Centre has approved the Ankleshwar plant of Bharat Biotech for the production of Covaxin

Union minister Mansukh Mandaviya announced yesterday that the government has approved Bharat Biotech's Ankleshwar-based manufacturing plant to produce the COVID-19…

3 years ago

Is Bharat Biotech’s Nasal Spray efficient against Covid?

An expert panel of India's central drug authority has recommended that Bharat Biotech be given permission to conduct a study…

3 years ago

Covaxin trials on children expected to start in June: Bharat Biotech

Bharat Biotech, the maker of coronavirus disease vaccine Covaxin, is expected to start paediatric trials from June, the company's Business…

3 years ago

Bharat Biotech is ramping up its manufacturing capacity to 700 million doses which is likely to be achieved by the end of this year: Dr. Raches Ella

Few side effects of vaccination are common and that shouldn’t deter anyone from taking it said Dr. Raches Ella, Head-Business…

3 years ago

Bharat Biotech to ramp up Covaxin production via new plant

Bharat Biotech on Thursday said it has ramped up additional manufacturing capacities for the Covaxin covid-19 jabs as the country…

3 years ago

Breaking: DCGI approves Phase II/III clinical trial of COVAXIN in the age group of 2 to 18 Years

The National Regulator of the country, the Drugs Controller General of India (DCGI), after careful examination, has accepted the recommendation…

3 years ago

Price of Bharat Biotech’s Covaxin reduced to Rs. 400 for state govt

In a recent announcement made by Bharat Biotech, the price of its Covid-19 vaccine, Covaxin has been reduced from Rs.…

4 years ago

COVAXIN shows 100% efficacy against COVID-19

COVAXIN shows 78% clinical and 100% efficacy against severe COVID-19 The COVAXIN developed and manufactured by Bharat Biotech, “neutralizes multiple…

4 years ago

SII and Bharat Biotech granted Rs. 45.67 billion to boost vaccine production

India’s government has granted Rs. 45.67 billion to Serum Institute of India (SII) and Bharat Biotech to boost production of…

4 years ago